Pathalys Pharma is a biopharmaceutical company developing treatments for chronic kidney disease, with a focus on managing hyperphosphatemia in patients.
1
Funding Rounds
$105.0m
Money raised
Access comprehensive data and insights available only to Seedtable members
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide